Lanfumey Laurence, Hamon Michel
UMR 677; INSERM-UPMC, Faculté de Médecine Pitié-Salpêtrière, Paris, France.
Therapie. 2005 Sep-Oct;60(5):431-40. doi: 10.2515/therapie:2005064.
Monoaminergic systems, and in particular serotoninergic neurons of the raphe system, have been involved in the physiopathology and treatment of major depression in a great number of studies. One of the most reproducible effects of antidepressant treatment is the increase of central 5-HT (serotonin) tone. However, the identification of novel potential therapeutic targets (neurohormones, neuropeptides) for treating depression has led to elaborating novel cellular and molecular concepts accounting for stress-related mood disorders. In particular, recent studies have demonstrated that chronic administration of all classes of antidepressants up-regulates neurogenesis in adult rodent hippocampus. The possibility that structural remodelling may contribute to the physiopathology of mood disorders provides new avenues of research toward understanding the cellular basis of mood disorders.
在大量研究中,单胺能系统,尤其是中缝系统的5-羟色胺能神经元,已被证实与重度抑郁症的生理病理学及治疗密切相关。抗抑郁治疗最具重复性的效果之一是中枢5-羟色胺(血清素)水平的升高。然而,用于治疗抑郁症的新型潜在治疗靶点(神经激素、神经肽)的发现,促使人们提出了新的细胞和分子概念,以解释与应激相关的情绪障碍。特别是,最近的研究表明,长期给予各类抗抑郁药可上调成年啮齿动物海马体中的神经发生。结构重塑可能导致情绪障碍的生理病理学这一可能性,为理解情绪障碍的细胞基础提供了新的研究途径。